Roche Holding AG (RHHBY) Competitors & Peers
The 5 largest companies in the same industry as Roche Holding AG, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| LLY | Peer | $1,183.46 | P/E 39.7RSI 56Cap 1.06 T |
| JNJ | Peer | $271.22 | P/E 31.5RSI 57Cap 653.6 B |
| ABBV | Peer | $264.34 | P/E 74.5RSI 59Cap 467.1 B |
| MRK | Peer | $148.78 | P/E 119.0RSI 58Cap 367.1 B |
| AZN | Peer | $166.58 | P/E 24.9RSI 54Cap 258.3 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- ROIVPartner
Roche acquired Telavant (a JV created by Roivant and Pfizer) to gain rights to VTAMA/RVT-3101.
Model-inferred, unverified — treat as a lead, not evidence